INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 176 filers reported holding INSMED INC in Q2 2019. The put-call ratio across all filers is 1.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,689,912 | -21.1% | 127,484 | -36.3% | 0.02% | -33.3% |
| Q1 2023 | $3,410,000 | +13.8% | 200,000 | +33.3% | 0.03% | -3.2% |
| Q4 2022 | $2,997,000 | -12.7% | 150,000 | +4.3% | 0.03% | -31.1% |
| Q4 2019 | $3,433,000 | -27.5% | 143,765 | -46.4% | 0.04% | -33.8% |
| Q3 2019 | $4,735,000 | -5.5% | 268,419 | +37.1% | 0.07% | +4.6% |
| Q2 2019 | $5,012,000 | -45.2% | 195,785 | -49.3% | 0.06% | -20.7% |
| Q2 2018 | $9,138,000 | -4.3% | 386,372 | -8.9% | 0.08% | +3.8% |
| Q1 2018 | $9,549,000 | -2.3% | 424,017 | +35.2% | 0.08% | +1.3% |
| Q4 2017 | $9,776,000 | +6.1% | 313,537 | +6.2% | 0.08% | +13.0% |
| Q3 2017 | $9,210,000 | +485.9% | 295,098 | +228.7% | 0.07% | +430.8% |
| Q1 2017 | $1,572,000 | -38.1% | 89,786 | -53.2% | 0.01% | -38.1% |
| Q4 2016 | $2,540,000 | +6.2% | 192,020 | +67.0% | 0.02% | -36.4% |
| Q1 2015 | $2,392,000 | – | 115,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |